Premium
Identifying at diagnosis the vestibular schwannomas at low risk of growth in a long‐term retrospective cohort
Author(s) -
Wolbers J.G.,
Dallenga A.H.G.,
Linge A.,
West M.,
Kummer E.E.,
Méndez Romero A.,
Pauw B.K.H.,
Wieringa M.H.
Publication year - 2016
Publication title -
clinical otolaryngology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.914
H-Index - 68
eISSN - 1749-4486
pISSN - 1749-4478
DOI - 10.1111/coa.12661
Subject(s) - medicine , schwannoma , retrospective cohort study , cohort , hazard ratio , vestibular system , acoustic neuroma , population , vertigo , hearing loss , surgery , radiology , pediatrics , audiology , confidence interval , environmental health
Objectives Identification at time of diagnosis of those vestibular schwannomas that will not grow. Design Retrospective cohort study of consecutive patients diagnosed with a sporadic vestibular schwannoma that were entered in the wait‐and‐scan protocol. Setting Academic referral centre. Participants The study group contained 155 patients with a sporadic vestibular schwannoma first seen in the full 8‐year period 2000–2007: continual wait‐and‐scan ( n = 89) and initial wait‐and‐scan until intervention ( n = 66). Main outcome measures Tumour growth, defined as more than 2 mm linear difference in any plane between the diagnostic MRI ‐scan and the last available scan, was related to clinical parameters at diagnosis: localisation of the tumour (solely intracanalicular versus cisternal extension), sudden sensorineural hearing loss, sensorineural hearing loss longer than 2 years and vertigo/instability. Results Hearing loss longer than 2 years and an entirely intracanalicular localisation were associated with no tumour growth by univariate and multivariate Cox analysis. Combining both factors at time of diagnosis resulted in a group with low risk of growth ( n = 36, median follow‐up of 6.2 years) with a Hazard Ratio for growth of 0.37 (95% CI , 0.19–0.69). This subgroup is about 25% of the wait‐and‐scan population. Thirty‐one percent showed growth, while in the remaining higher risk group of 119 patients 62% showed growth. For the growing schwannomas, the median time for growth becoming manifest is 1.9 years after diagnostic MRI . Conclusions In this study on vestibular schwannoma patients that start in a wait‐and‐scan protocol, about a quarter may be set apart having a low risk for growth. These patients at diagnosis combine a history of hearing loss longer than 2 years and a fully intracanalicular schwannoma. They seem to be not needed yearly MRI checks.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom